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Septins are a conserved group of GTP-binding proteins that form hetero-oligomeric complexes which
assemble into ﬁlaments. These are essential for septin function, including their role in cytokinesis, cell
division, exocytosis and membrane trafﬁcking. Septin 2 (SEPT2) is a member of the septin family and has
been associated with neuroﬁbrillary tangles and other pathological features of senile plaques in Alz-
heimer’s disease. An in silico analysis of the amino acid sequence of SEPT2 identiﬁed regions with
a signiﬁcant tendency to aggregate and/or form amyloid. These were all observed within the GTP-binding
domain. This was consistent with the experimental identiﬁcation of a structure rich in b-sheet during
temperature induced unfolding transitions observed for both the full length protein and the GTP-binding
domain alone. This intermediate state is characterized by irreversible aggregation and has the ability to
bind Thioﬂavin-T, suggesting its amyloid nature. Under electron microscopy, ﬁbers extending for several
micrometers in length could be visualized. The results shown in this study support the hypothesis that
single septins, when present in excess or with unbalanced stoichiometries, may be unstable and
assemble into amyloid-like structures.
 2011 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
The septins are members of a conserved group of GTP-binding
proteins, originally discovered in yeast as being required for the
completion of the cell cycle [1]. Septins have been identiﬁed in all
animals and fungi [2]. In mammals they are involved in a variety of
cellular phenomena, such as microtubule regulation [3,4], vesicle
trafﬁcking [5], the assembly of scaffolding platforms [6], actin
dynamics [7], exocytosis [8], apoptosis [9], DNA repair [10] and
mechanical stability [11e13].
All members of the septin family can be divided into three
domains: a variable N-terminal domain, a GTP-binding domain and
a C-terminal region, which generally includes sequences with the
potential to assemble as a coiled-coil [14]. In addition, some septins
have a polybasic region between the N-terminal and GTP-binding
domains, which is responsible for lipid interaction [15]. Both the
binding of GTP and its hydrolysis have been experimentally
demonstrated for several septins in vitro [2,16e18].: þ55 1633715381.
raújo).
.nder the Elsevier OA license.Septins can assemble into high-order hetero-ﬁlaments,
including two or more members of the family, in vivo and in vitro.
These hetero-ﬁlaments were isolated from Drosophila melanogaster
[19] and fungi [20], and shown to have a width of about 7e9 nm
and a variable length. Hetero-ﬁlaments were also identiﬁed in the
case of the Caenorhabditis elegans septins UNC-59 and UNC-61 [21].
Moreover, a complex of recombinant Saccharomyces cerevisiae
septins, Cdc3, Cdc10, Cdc11 and Cdc12, forms an elongated linear
octamer composed of two copies of each individual septin which
subsequently polymerize to form ﬁlaments [22]. Recently, Sir-
ajuddin et al. solved the crystal structures of both the human SEPT2
GTP-binding domain alone and the hetero-trimeric complex of
SEPT2eSEPT6eSEPT7 [23]. In both cases the crystal lattice leads to
the formation of ﬁlaments. In addiction, members of the same
group can replace each other in the speciﬁc position along the
heteroﬁlament [24].
Although the formation of hetero-ﬁlaments by septins and their
associated functions is relatively well established, information
concerning the existence and physiological role of homo-ﬁlaments
is puzzling. The ﬁrst report of ﬁlaments formed by a single septin
was that for Xenopus laevis SEPT2. The authors described homo-
ﬁlaments of 20 nm in width when the component monomers
were bound to GTP but not to GDP [25]. This observation has been
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of homo-ﬁlaments in the case of Xenopus septins [26]. However,
20e40 nm wide homo-ﬁlaments have also been reported for
human SEPT2 in both the GTP- and GDP-bound states [18]. The
question of the existence of homo-ﬁlaments is therefore unsettled
and has been complicated by the observation of homo-ﬁlaments of
human SEPT4, which are believed to be amyloid ﬁbers with no
physiological relevance [27].
SEPT2 is essential for cytokinesis, being located near the
contractile ring from anaphase to telophase and ﬁnally condensing
into themidbody [7]. It has awide tissue distribution and speciﬁcally
in the brain has been observed to co-localizewithGLAST, an astrocyte
glutamate transporter [28]. Based on this data SEPT2 has been sug-
gested to play a role in signal transmission in the cerebellum [28].
Besides its physiological roles, SEPT2 has also been implicated in
several pathologies including leukemia and lymphoma [29], renal
cell carcinoma [30], brain tumors [31,32] and systemic lupus eryth-
ematosus [33]. Moreover, SEPT2 together with SEPT1 and SEPT4
(all of which are acidic proteins) have been seen to accumulate in
neuroﬁbrillary tangles (NFTs) in Alzheimer’s disease [34] where they
co-localize with the basic microtubule-associated protein tau. So far,
however, the role of septins in NFT formation and the possible
mechanisms of self-aggregation of septins in neurodegenerative
disorders still remain unclear.
A wide range of human pathologies are associated with uncon-
trolled protein misfolding, leading to the conversion of polypeptide
chains from their soluble globular states into well-organized ﬁbrillar
aggregates rich in b-sheet structure [35,36]. Amyloid formation is the
hallmark of medically related disorders, such as Alzheimer disease,
andmore than 40 human related diseases have been described, each
having a distinct clinical proﬁle and each associated with the
aggregation of a single dominant protein [37].
With the aim of shedding some light upon this issue, the present
study uses a biophysical approach to investigate the stability and
aggregation of SEPT2. Our results show that both SEPT2 and its
GTP-binding domain (SEPT2G) are dimeric in solution, but they
have the tendency to rapidly aggregate at physiological tempera-
tures. These aggregates have the ability to bind Thioﬂavin-T, sug-
gesting that they are amyloids and providing the ﬁrst insight on the
mechanisms that cause the formation of the aggregates associated
with neurodegenerative diseases.
2. Material and methods
2.1. Materials and reagents
The bacterial expression vector pET28a(þ) and Ni-NTA resin
were purchased from Novagen. Restriction endonucleases, iso-
propyl-b-D-thiogalactopyranoside, kanamycin, T4 DNA ligase and
Taq Polymerase were obtained from Invitrogen. The Superdex-200
column 10/30 and native gels for electrophoresis [8e25% (w/v)
gradient polyacrylamide] were purchased from Amersham Phar-
macia Biotech (GE-Healthcare). Guanosine-50-diphosphate (GDP),
protein standard markers and ThT (Thioﬂavin-T) were purchased
from Sigma. All other chemical products used were obtained from
Sigma and/or GE-Healthcare.
2.2. In silico analysis
Essentially, protein aggregation is a self-assembly of identical
molecules [38], and these aggregates can be classiﬁed as either
ordered or disordered, on the basis of their intimate structural
features [39]. There is evidence that local unfolding events can cause
the aggregation of normally globular proteins into well-organized
ﬁbrils [40]. In order to identify possible regions presenting a highaggregation probability in SEPT2, we used the in silico analysis
programs TANGO, WALTZ and ZYGGREGATOR. TANGO is a statistical
mechanics algorithm which predicts protein aggregation, based on
the physico-chemical principles of b-sheet formation [41,42]. WALTZ
and ZYGGREGATOR are algorithms including additional thermody-
namic information in thepredictionof regionswith ahighprobability
to form amyloid sequences [43,44]. The amino acid sequence of
SEPT2 was submitted to these prediction programs using servers
based at http://tango.crg.es/ and http://waltz.switchlab.org/, using
default parameters. Additionally, the major isoforms of all 13 human
septin sequenceswere alsoanalyzedwithWALTZ inorder to compare
their predicted amyloidogenic regions.
2.3. Plasmid construction and proteins expression
Based on the results of the sequence analysis, which suggested
the presence of aggregation prone sequences within the GTP-
binding domain, a construct was designed corresponding to
a truncated SEPT2 protein covering this region of the molecule
(SEPT2G, residues 34e308). The cDNA corresponding to SEPT2
(residues 1e361) and its GTP-binding domain (SEPT2G) were
ampliﬁed using the polymerase chain reaction performed in
a Mastercycler thermocycler (Eppendorf), using a fetal brain cDNA
library (Gibco BRL) as template. Ampliﬁcation products were puri-
ﬁed and cloned into the pET28a(þ) expression vector, using NdeI
and XhoI restriction sites. The recombinant plasmids were trans-
formed into Escherichia coli DH5a for propagation and plasmid
extraction purposes. These were named pSEPT2 and pSEPT2G and
produced their respective products fused to an N-terminal His-tag.
All plasmids were sequenced by the dideoxy chain method [45]
using an ABI Prism 377 automated DNA sequencer (PerkineElmer)
following the protocol of the manufacturer.
The expression plasmids were used to transform the E. coli host
strain BL21(DE3). A total of 500 mL of an overnight culture of E. coli
BL21(DE3) harboring the pSEPT2 plasmid were inoculated into
500 mL of fresh LB medium containing kanamycin (50 mg/mL). The
culture was grown whilst shaking at 37 C to mid log phase
(O.D.600nm ¼ 0.6) and subsequently induced with IPTG at a ﬁnal
concentration of 0.4 mM followed by incubation for 10 h at 18 C.
After centrifugation, the pelleted cells were re-suspended in
25 mM TriseHCl pH 7.8 buffer, containing 100 mM GDP and 10%
glycerol. The cells were disrupted by the addition of 0.1 mg/mL
lysozyme for 30min at 4 C, followed by sonication. The suspension
was then centrifuged at 18,000 g for 20 min at 4 C, and the pellet
and supernatant were analyzed by SDS-PAGE to check the solubility
of the recombinant protein. The supernatant containing the
recombinant SEPT2 was loaded onto a nickel-afﬁnity column
equilibrated with the same buffer. After the unbound proteins were
eliminated by exhaustive washing, SEPT2 was eluted by increasing
concentrations of imidazole up to 300 mM.
The resulting SEPT2 was then loaded onto a Superdex-200
10/300 GL column (GE-Healthcare) pre-equilibrated with 25 mM
TriseHCl pH7.8 buffer, containing 10% glycerol and driven by anÅkta
puriﬁer. The elution was carried out in the same buffer, at 4 C and
fractions analyzed by means of 15% SDS-PAGE. Protein elution was
monitored byabsorbance at 280nm. The elution volumes of standard
proteins were used to calculate the Kav values [Kav ¼ (elution
volume columnvoid volume)/(total columnvolume columnvoid
volume)]. The standard proteins of known molecular weight were
carbonic anhydrase (29 kDa), ovoalbumin (43 kDa), conalbumin
(75 kDa), ferritin (440 kDa) and lactoglobulin (669 kDa). An identical
protocol was used for the puriﬁcation of SEPT2G. The protein
concentration, in all cases, was determined from its absorbance at
280 nm, based on its amino acid composition [46], employing
a U-2001 Hitachi UVevisible spectrophotometer.
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SEPT2 (20 mM) and SEPT2G (20 mM) were centrifuged at
13,000  g for 5 min at 4 C. Subsequently the samples were sub-
jected to electrophoresis on an 8e25% (w/v) gradient poly-
crylamide gel at pH 8.8 using the Phast System (Amersham
Bioscience), at 4 C, and stained following standard protocols.
Protein standards of known hydrodynamic radii (thyroglobulin,
8.5 nm; ferritin, 6.1 nm; catalase, 5.22 nm; lactate dehydrogenase,
4.4 nm; and bovine serum albumin, 3.55 nm) were subjected to
electrophoresis under identical conditions. The mobilities of the
individual bands of the protein standards were plotted as the
retardation factors (Rf) versus the Stokes radii (Rh). The linear
equation obtained from this calibration was employed to calculate
the Rh of SEPT2 and SEPT2G.2.5. Circular dichroism spectroscopy (CD)
The thermal unfolding of the recombinant proteins, SEPT2 and
SEPT2G was monitored by far-UV CD spectroscopy over a wave-
length range of 195e250 nm, using a J-715 Jasco spectropolarimeter
equipped with a temperature controller. CD spectra weremeasured
from samples in 0.1 cm quartz cuvettes and were the average of 16
accumulations, using a scanning speed of 100 nm min1, a spectral
bandwidth of 1 nm, and a response time of 0.5 s. The protein
concentration, in all cases, was approximately 10 mM in 25 mM
TriseHCl, pH 7.8 buffer containing 10% glycerol. Thermal denatur-
ationmeasurements were performed by incubating the samples for
30 min at temperatures of 15 C, 30 C, 37 C, 45 C and 60 C. CD
spectra were obtained on a degree ellipticity scale and the buffer
contribution was subtracted in all of the experiments. Data points
were analyzed with the software Origin 7.0 and deconvolution of
the spectrumwas performed using the K2d algorithm (http://www.
embl-heidelberg.de/wandrade/k2d/).2.6. Right-angle light scattering
SEPT2 and SEPT2G (5 mM) in 25 mM TriseHCl, pH 7.8 buffer
containing 10% glycerol were centrifuged (16,000  g for 10 min
at 4 C) and each sample placed in a 1 cm path length quartz
cuvette in a spectroﬂuorimeter, model K2 ISS, equipped with
a refrigerated circulator. The samples were illuminated with
350 nm light, and the scattering at the same wavelength was
collected at an angle of 90. Measurements were made at 15 C,
30 C, 37 C, 45 C and 60 C. All intensity measurements were
normalized to values between 0 and 1 (where the latter corre-
sponds to the maximum intensity obtained at 60 C) after
subtraction of the light scattering by the buffer. Data points were
analyzed with the software Origin 7.0.2.7. Thioﬂavin-T ﬂuorescence assay
Thioﬂavin T (ThT) is the most commonly used dye for the
detection of amyloid aggregates [47,48], and it is speculated that
ThT may bind in between the b-sheets of the ﬁbril [49]. Proteins at
5 mM (in 25 mM TriseHCl, 10% glycerol, pH 7.8 buffer) were used in
this experiment to analyze the ThT binding to SEPT2 and SEPT2G.
The proteins were incubatedwith 80 mMThT, excited at 450 nm and
the emission measured at 482 nm for a period of 90 min.
Measurements weremade at 15 C, 30 C, 37 C, 45 C and 60 C. All
intensity measurements were normalized to values between 0 and
1, after subtraction of the light scattering by the buffer. Data points
were analyzed with the software Origin 7.0.2.8. Electron microscopy
In order to verify the morphology of the SEPT2 aggregates, the
sample (5 mM) was maintained at 37 C for 30 min in buffer con-
taining 25 mM TriseHCl, 10% glycerol, pH 7.8. Samples incubated at
4 C for 5 days were also prepared in order to decrease the rate of
amyloid ﬁlament formation. Negative staining was performed as
follows. Initially samples were applied to glow-discharged carbon-
coated grids for 1 min. These were stained with ﬁltered 1% uranyl
acetate for 1 min, subsequently washed with a drop of the same
buffer and blotted dry. Images were acquired with a transmission
electron microscope Philips CM 120 or a JEOL JEM 1230, working at
80 or 100 kV.
3. Results and discussion
3.1. SEPT2 presents regions with high probability of aggregation
and/or amyloid formation
It is accepted that two mechanisms appear to control the
assembly of amyloid oligomers, one sequence-dependant and the
other sequence-independent [50]. Obviously, the sequence-
dependant mechanism is more predictable and the programs
TANGO and WALTZ are very sensitive for the detection of b-sheet
aggregation and amyloidogenic regions, respectively [41,43]. The
TANGO results indicated four regions of SEPT2 presenting a high
probability of aggregation through b-sheets, all of them within the
GTP-binding domain. The sequences identiﬁed included those
between residues 38 and 43 (FTLMVV), 52 and 59 (TLINSLFL), 118
and 122 (IISYI) and 146 and 153 (VHCCFYFI) (Fig. 1A). Although
TANGO aims to predict b-sheet aggregation but not speciﬁcally
amyloid formation, there is a good correlation between the two [41].
The program WALTZ aims to minimize the over prediction of
amorphous b-aggregation compared to the regular cross-b structure
characteristic of amyloid ﬁbrils, making it more speciﬁc for the latter
[51]. WALTZ also identiﬁed four regions within SEPT2 which pre-
sented a high amyloidogenic potential: the sequences between
residues 118 and 123 (IISYID), 147 and 155 (HCCFYFISP), 163 and 168
(LDVAFM), 173 and 178 (NKVNIV) (Fig. 1A). Once again these regions
were all restricted to the GTP-binding domain and two of theWALTZ
predictions were effectively identical to those identiﬁed by TANGO,
being highly suggestive that these regions have a tendency towards
self-assembly and amyloid formation. The region from 118 to 123
corresponds to a helical region on the surface of themonomerwhilst
that from147 to 155maps to a buriedb-strand. They are shown in red
andblue in Fig.1B andC. Furthermore, bothof these regionswere also
identiﬁed by the independent algorithm Zyggregator. In both cases
considerable structural rearrangement of the monomer would
therefore be necessary in order for these particular sequences to
become solvent exposed and directly participate in the cross-b spine,
eventually leading to aggregation. In order to investigate this further,
SEPT2 and SEPT2G were over-expressed for structural analysis.
3.2. SEPT2 and SEPTG are dimers in solution
The deﬁnition of the GTP-binding domain for SEPT2 was based
on that used in a previous study of the molecular dissection of
SEPT4 [52]. DNA ampliﬁcations produced fragments of 1083 and
822 bp corresponding to the coding regions of SEPT2 and SEPT2G,
respectively. After induction with IPTG, E. coli cells harboring the
appropriate expression vector produced additional bands of around
44 and 34 kDa corresponding to SEPT2 and SEPT2G, respectively. In
both cases, the majority of the expressed product was soluble after
cell lysis and ﬁnal yields were typically 3 and 10 mg of recombinant
protein/L of culture medium for SEPT2 and SEPT2G, respectively.
Fig. 2. Elution proﬁle of SEPT2 and its GTP-binding domain (SEPT2G) on Size Exclusion
Chromatography. Both proteins eluted as dimers in solution in the presence of GDP.
Excess nucleotide corresponds to the peak observed close to fraction 25. The elution
volumes of standard proteins were used to calculate Kav values (inset). The main peak
position corresponded to about 91 kDa for SEPT2 and 60 kDa for SEPT2G.
Fig. 1. In silico sequence analysis of SEPT2 (A). The programs TANGO and WALTZ
indicate four regions with a high probability (>60%) of b-sheet aggregation and
amyloid formation, respectively. (B): The 3D structure of SEPT2 (2QA5 pdb code)
showing the regions predicted by TANGO: 38FTLMVV43 (cyan), 52TLINSLFL59
(yellow), 118IISYI122 (red), 146VHCCFYFI153 (blue); (C): SEPT2 showing the regions
predicted by WALTZ: 118IISYID123 (red), 147HCCFYFISP155 (blue), 163LDVAFM168
(purple), 173NKVNIV178 (black). Two effectively identical regions were identiﬁed
within the GTP-binding domain by both programs. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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shown), as previously reported [18].
Upon SEC, the full length SEPT2 molecule eluted as a single peak
of apparent molecular weight of around 91 kDa (Fig. 2, solid line),
which is consistent with a dimer, whose expected mass is 88 kDa.
This is broadly supported by the results of native gel electrophoresis,
which showed a major band migrating below lactate dehydroge-
nase (140 kDa) (Fig. 3B, lane 2). The hydrodynamic radius calculated
for SEPT2 from its Rf value was 4.6 nm, corresponding a molecular
weight of approximately 120 kDa, considering a spherical particle.
This value is compatible with a dimer or a trimer for SEPT2 in
solution under native conditions, but deﬁnitive conclusions are
limited by the fact that a SEPT2 dimer would not be expected to be
a spherical particle.SEPT2G eluted as a single peak with an apparent molecular
weight of approximately 60 kDa (Fig. 2, dotted line), consistent
with a dimer, whose expected mass is 68 kDa. Furthermore, the
native gel showed a major bandmigrating similarly to BSA (67 kDa)
(Fig. 3B, lane 3). The hydrodynamic radius of SEPT2Gwas calculated
to be 3.9 nm, corresponding to a molecular weight of 74 kDa,
consistent with a dimer under native conditions. The recombinant
proteins migrated with the expected molecular mass under dena-
turing conditions in 15% SDS-PAGE (Fig. 3A). Taken together, these
data indicate that both human SEPT2 and SEPT2G are dimeric
molecules in solution, agreeing with the structural results obtained
for human SEPT2-315, which shows that the dimer is stabilized by
interactions across the nucleotide-binding G interface [23].3.3. At higher temperatures SEPT2 and SEPT2G show
a structural transition
Amyloidogenic proteins are rich in b-sheet secondary structure
in which the strands lie orthogonal to the ﬁber axis [53]. Structural
transition of buried segments in protein chains into solvent-
exposed b-strands is a remarkable characteristic of a number of
conformational diseases [41,54e56]. Circular dichroism was there-
fore used to probe SEPT2 and SEPT2G in order to investigate if the
dimeric structure described above is susceptible to such structural
transitions. At 15 C, the far-UV CD of both spectra exhibit two
negative minima at 208 nm and 220 nm, which are characteristic of
the presence of a-helical secondary structure. The deconvolution of
the SEPT2G spectrum led to an estimated content of 25% a-helix,
24% b-strand and 50% turns/irregular structures. This is compatible
with the data from the tridimensional structure of SEPT2-315 (2QA5
pdb code, Fig. 1), which gave values of 32% a-helix and 15% b-strand
and 53% turns/irregular structures. However, it should be pointed
out that the construct used in the crystallographic studies is slightly
different from that described here.
On increasing the temperature, marked changes in the
secondary structure of SEPT2 took place (Fig. 4A and B). Above 30 C
loss in the a-helical content can be readily observed. This can be
followed by the change in the ellipticity at 220 nm, which is the
dominant trough characteristic of a-helical structure. This is clearer
in SEPT2G, which lacks the C-terminal coiled-coil domain,
responsible for a signiﬁcant percentage of the helical component in
Fig. 4. Thermal unfolding of SEPT2 and SEPT2G. Circular Dichroism (CD) spectra as
a function of temperature were recorded in 25 mM TriseHCl pH 7.8, 10% Glycerol. In
both cases, although no signiﬁcant change to the CD spectrum could be observed from
15 C to 30 C, above this temperature a loss in the characteristic transitions indicating
the presence of a-helix can be observed the spectral proﬁle.
Fig. 3. A) SEPT2 proﬁle on 15% SDS-PAGE. Lane 1: Molecular weight markers; Lane 2:
SEPT2; Lane 3: SEPT2G. B) SEPT2 under Native Gel Electrophoresis (8e25%). Lane 1:
Molecular weight markers; Lane 2: SEPT2; Lane 3: SEPT2G. The estimated hydrody-
namic radii were 4.6 nm for SEPT2 and 3.9 nm for SEPT2G.
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characteristics of b-sheet structure, with a minimum between
215 nm and 220 nm, consistent with the results of deconvolution of
the spectrummeasured at 45 C, which yielded 15% a-helix, 35% b-
strand and 50% turns/irregular structures. Above 60 C, the spec-
trum looses overall intensity and the sample begins to precipitate.
3.4. Formation of high order particles in solution
In order to evaluate whether the heat treatment was promoting
aggregation of the proteins, right-angle light scattering (RALS)measurements were performed. Initially, SEPT2 (Fig. 5A) and
SEPT2G (Fig. 5B) were measured at temperatures between 15 C
and 60 C, and RALS was followed as a function of time. In both
cases, the intensity of scattered light remained constant at 15 C for
the entire duration of the experiment, indicating that no protein
aggregationwas detectable under these conditions. However, in the
interval from 30 C to 60 C the intensity of light scattering
increased over time in a temperature dependent manner, reaching
a maximum intensity at 60 C. This intensity subsequently
remained constant over time and there was no evidence of protein
precipitation. These data suggest the temperature dependent
formation of larger particles in solution. SEPT2 showed a more
rapid aggregation than SEPT2G suggesting that the presence of the
non-globular N- and C-terminal domains may lead to rapid amor-
phous aggregation.3.5. SEPT2 and SEPT2G bind ThT
ThT exhibits enhanced ﬂuorescence upon binding to amyloid
ﬁbrils, both in vivo and in vitro [37] and this was monitored at
482 nm in the case of SEPT2 (Fig. 6A) and SEPT2G (Fig. 6B) on
incubation at the same temperatures used to study protein
Fig. 6. ThT ﬂuorescence emission spectra of SEPT2 and SEPT2G as a function of
temperature. Fluorescence emission was monitored at 482 nm after excitation at
450 nm. In both cases, some degree of ThT binding (indicative of amyloid formation)
can be observed even at 30 C. At 45 C the greatest degree of binding is observed,
reaching a maximum after approximately 1000 s. At 60 C a rapid increase in the
ﬂuorescence emission is observed during the ﬁrst few minutes in the case of SEPT2G
which is followed by a reduction in the emission intensity due to the formation of
amorphous aggregates.
Fig. 5. Right angle light scattering of SEPT2 and SEPT2G as a function of temperature.
Scattering intensity at 350 nmwas measured as a function of time at each temperature
for the two samples. Both proteins show a rapid aggregation at temperatures above
30 C.
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a maximumvalue in both cases, and this behavior was temperature
dependent. In the case of the measurements made at 45 C, the
plateau could be clearly seen and was reached after approximately
1000 s. This is the temperature at which the structure rich in
b-sheet, strongly suggestive of amyloid formation, is observed on
thermal unfolding. Indeed, at 37 C and 45 C both proteins
released the nucleotide, which is normally buried within the
GTPase domain (Supplementary material, Figure S1). At higher
temperatures (above 45 C) there is a reduction in the maximum
ﬂuorescence intensity reached indicating an increase in the
formation of amorphous aggregates rather than amyloid. Such
aggregates are expected to be the result of rapid partial unfolding of
the protein at higher temperatures and the consequent exposure of
hydrophobic regions. These contribute to light scattering but
cannot be detected by ThT ﬂuorescence emission. Furthermore,
incubation of SEPT2G with DTNB (5,50-dithiobis,2-nitrobenzoic
acid) [57] demonstrated an increase in binding as a function of
temperature followed by a sharp decline above 37 C (data not
shown). This is consistent with the initial exposure of the region
147HCCFYFISP155, (which contains two of the protein’s four
cysteine residues) followed by its subsequent burial, coherent with
the participation of this region in amyloid formation.An interesting difference can be observed between the two
constructs studied. SEPT2G shows a sharp rise in ThT ﬂuorescence
emission at 60 C demonstrating the initial rapid formation of
amyloid-like structures which subsequently becomes dominated
by amorphous aggregation leading to a ﬂattening of the curve. This
behavior can be veriﬁed by comparing the corresponding curves in
Figs. 5 and 6B. SEPT2 aggregation at 60 C, on the other hand,
appears to involve a greater amorphous component right from the
outset. These results suggest that the GTP-binding domain is
sufﬁcient for the formation of amyloid-like structures as predicted
by the results of the sequence analyses with TANGO and WALTZ.
The difference in the behavior of the two constructs can be
attributed to the presence of the N- and C-terminal domains in the
case of SEPT2 which are not predicted to be involved in amyloid
formation but could readily contribute to other forms of protein
aggregation at higher temperatures.
Ideally, in order to verify the direct participation of the predicted
regions in amyloid formation, mutagenesis of these sequences
would be necessary. However, an exhaustive study of potential
mutations using the CUPSAT algorithm [58] indicated the majority
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involvement of more than one amyloidogenic region, a series of
single and double mutants would be necessary in order to properly
test this hypothesis. Unfortunately, these limitations would lead to
considerable ambiguity when interpreting the outcome.3.6. Amyloid like ﬁlaments are visualized by electron microscopy
To evaluate the formation of amyloid-like ﬁbers, SEPT2 was
incubated at 37 C for 30 min (Fig. 7A). At this temperature, chosen
to be below that at which SEPT2 rapidly binds ThT, the samples
have the ability to form amyloid-like aggregates similar to those
observed for SEPT4 [27]. It was also observed the presence of
amorphous aggregates, probably due to the time and temperature
that the sample was incubated. In an attempt to decrease the
velocity of this process even further, SEPT2 was incubated at 4 C
for 120 h. Under these conditions we observed a small number of
well-deﬁned ﬁlaments of 20 nm in diameter and lengths of up to
several micrometers (Fig. 7B). At this lower temperature the sample
still bound ThT, but at a much reduced rate (in 90 min there is no
detection of ThT binding), compared with 45 C (Supplementary
material, Figure S2). This strongly suggests that ﬁlament forma-
tion can occur over a wide range of temperatures but is accelerated
on heating.
An overall picture emerges in which the natural tendency of the
GTP-binding domain of SEPT2 to form amyloid-like aggregates is
exacerbated at temperatures, which favor the partial unfolding of
the protein and the appearance of b-structure. The latter may be
new structures, for example the conversion of an a-helix into
a b-strand, or alternatively the exposure of buried strands uponFig. 7. Electron microscopy. Negatively-stained electron micrograph of SEPT2 ﬁbrils
after incubation at: (A) 37 C for 30 min and (B) 120 h at 4 C. A scale bar is indicated in
each image. The ﬁlaments observed in (B) present diameters of 20 nm and lengths up
to several micrometers.partial unfolding. These will tend to aggregate to form the cross-
b spine described for other systems [27,37e40,53,59]. Similar
observations have been reported for SEPT4, suggesting that
a similar phenomenon may be at work [27,60]. The results of
a WALTZ analysis of all 13 human septins revealed at least one
amyloidogenic region within each GTP-binding domain suggesting
this to be a general characteristic of the septin family members.
Furthermore, one of the two coincident regions given for SEPT2 by
both TANGO and WALTZ (that corresponding to the region around
residue 150) was also predicted to be amyloidogenic in all 13
human septins. This may indicate a general tendency for all family
members to aggregate and it may be worthwhile investigating the
possible involvement of different septins in other amyloidogenic
conditions. Since this region corresponds to a buried b-strand,
signiﬁcant structural rearrangement would be necessary for it to
become directly involved in the formation of the cross-b spine.
Given the physiological role of septins in ﬁlament formation,
knowledge on their ability to form amyloids is important as it is
fundamental to be able to distinguish between these two types of
assemblies. Reports of homo-ﬁlaments in the literature are scarce
[18,25] and their physiological relevance requires further inves-
tigation. Interestingly, the diameters of some of the ﬁbers
described here for SEPT2 are similar to those previously reported
for SEPT4 [27].
4. Conclusions
Septins have been associated with certain neurodegenerative
disorders. In particular, SEPT2 has been found to be associated with
neuroﬁbrillary tangles and other pathological features of senile
plaques in Alzheimer’s disease. Since the signiﬁcance of this ﬁnding
is unclear, it is important to gain a better understanding of the
intrinsic aggregation properties of SEPT2.
In silico prediction programs indicated that the GTP-binding
domain of SEPT2 contains regions with a high probability of
involvement in aggregation and amyloid formation. This was borne
out by experimental data from CD measurements which show
a relative loss of a-helical content and a gain in b-sheet structure at
around 45 C, coincident with the tendency to bind the amyloid-
speciﬁc dye ThT. Although it is not rare for globular proteins to be
induced to form amyloid structures in vitro under harsh conditions
(such as low pHs or high salt concentrations), in the case of SEPT2
and SEPT2G this occurs under near physiological conditions, sug-
gesting that their tendency toward amyloid formation may be
relevant to the pathological conditions in which they have been
implicated, including Alzheimer’s disease.
In summary, these studies should provide a useful basis for
future biophysical studies of septin aggregation mechanisms and
their role in nervous system disorders. Further studies will be
necessary to address whether Septin 2 participates in the devel-
opment of neurodegenerative diseases or its amyloidosis is
a consequence of the underlying pathological processes.
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